Memorandum of Understanding between AFFINOMICS, NIH and Human Protein Atlas

In September 2013, the AFFINOMICS consortium signed a Memorandum of Understanding (MOU) with the Protein Capture Reagents Program, part of the NIH Office of the Director, and the Human Protein Atlas. The purpose of the MOU is to set up cooperative activities in the production and use of protein affinity reagents. The three programs have unique missions but many common goals. The cooperation guided by this MOU should benefit all programs and the main goal of generating valuable resources for protein affinity reagents for the scientific community.

AFFINOMICS consortium welcomes associate partners
Following the annual consortium meeting in 2013, the AFFINOMICS steering committee agreed to include 3 associate partners into the consortium:

    Wilfrid Boireau, Département Micro Nano Sciences & Systèmes, L'institut FEMTO-ST, France [link]
    Peter Kloehn, MRC Prion Unit, UCL Institute of Neurology, UK [link]
    Fridtjof Lund-Johansen, Institute of Immunology, Oslo University Hospital, Norway [link]